Veranex announced today that it acquired Experien Group, a provider of regulatory, quality and clinical consulting services for medtech companies.
Raleigh, N.C.-based Veranex, which was created as a combination of companies after Summit Partners acquired Ximedica, Quartesian and Boston Healthcare Associates in June, offers integrated product development strategies and services to medtech companies.
According to a news release, Veranex’s west coast operations will offer a unique, client-responsive consulting model designed to adjust to meet client program requirements as a result of the acquisition.
“We are excited to welcome Experien Group to Veranex,” Veranex CEO David Dockhorn said in the release. “With this acquisition, Veranex adds the premier provider of regulatory, quality, and clinical consulting services to medtech companies. Veranex’s clients will benefit from Experien’s long-standing FDA engagement, well-established global regulatory guidance experience, and a demonstrated track record of successful approvals.”
Financial terms for the acquisition were not disclosed.
“Experien Group adds another layer of value and medtech insight to Veranex,” added Veranex executive chairman Pat Donnelly. “We will continue to seek additional strategic acquisitions that add depth and resources to the full-service, end-to-end medtech solutions that Veranex has brought to the industry for the first time.”
